Hot line:010-83057670
ENGood News | Leadingpharm CXO · Deep Blue Ocean Bio-Pharmaceutical Approved as Henan Provincial MAH Platform and Liquid Preparation Engineering Technology Research Center
Release time：2025-01-13
Recently, the Henan Provincial Department of Science and Technology announced the list of Henan Provincial Engineering Technology Research Centers for 2024. The "Henan Provincial MAH Platform and Liquid Preparation Engineering Technology Research Center" applied by Leadingpharm CXO · Deep Blue Ocean Bio-Pharmaceutical was successfully approved. This is another provincial-level or above honor obtained by the company following titles such as "High-Tech Enterprise" and "Henan Provincial Specialized, Refined, Characteristic and Novel Small and Medium-Sized Enterprise".
Henan Provincial Engineering Technology Research Centers are mainly built relying on institutions with strong scientific research capabilities such as technology-based enterprises, colleges and universities, and research institutes. They aim to strengthen the dominant position of Henan's enterprises in technological innovation, improve the level of industrial innovation and development, and promote the agglomeration of various innovation factors to enterprises. They are an important part of building a technological innovation system with enterprises as the main body, market orientation, and in-depth integration of industry, university, research and application. They also serve as important platforms for gathering and training high-level engineering and technical talents, conducting research on key common technologies in industries, and serving high-quality industrial development.
The MAH Platform and Liquid Preparation Engineering Technology Research Center applied by Leadingpharm CXO · Deep Blue Ocean Bio-Pharmaceutical focuses on the research and development, registration, and production transformation of liquid preparations (such as water injections, lyophilized powder injections, sterile powder injections, oral liquids, inhalation preparations, eye drops, etc.) to meet the needs of domestic and foreign pharmaceutical enterprises for liquid preparation product development. At the same time, it promotes and builds a drug MAH sharing platform to realize the aggregation of all-element resources and precise information docking for drug MAH development, curb low-level redundant construction, and further improve the innovation capability of the pharmaceutical industry in Henan Province and even the whole country.
In the future, Deep Blue Ocean Bio-Pharmaceutical will continue to deepen its efforts in the field of pharmaceutical research and development, implement the innovation-driven development strategy, strengthen construction in industrial technological innovation, transformation of scientific and technological achievements, and training of high-level technical talents. It will adhere to the concept of open communication, industry-university-research cooperation, and collaborative innovation, connect the industrial chain upstream and downstream, and help improve the overall technical level of the pharmaceutical industry in Henan Province.
-END-
Henan Provincial Engineering Technology Research Centers are mainly built relying on institutions with strong scientific research capabilities such as technology-based enterprises, colleges and universities, and research institutes. They aim to strengthen the dominant position of Henan's enterprises in technological innovation, improve the level of industrial innovation and development, and promote the agglomeration of various innovation factors to enterprises. They are an important part of building a technological innovation system with enterprises as the main body, market orientation, and in-depth integration of industry, university, research and application. They also serve as important platforms for gathering and training high-level engineering and technical talents, conducting research on key common technologies in industries, and serving high-quality industrial development.
The MAH Platform and Liquid Preparation Engineering Technology Research Center applied by Leadingpharm CXO · Deep Blue Ocean Bio-Pharmaceutical focuses on the research and development, registration, and production transformation of liquid preparations (such as water injections, lyophilized powder injections, sterile powder injections, oral liquids, inhalation preparations, eye drops, etc.) to meet the needs of domestic and foreign pharmaceutical enterprises for liquid preparation product development. At the same time, it promotes and builds a drug MAH sharing platform to realize the aggregation of all-element resources and precise information docking for drug MAH development, curb low-level redundant construction, and further improve the innovation capability of the pharmaceutical industry in Henan Province and even the whole country.
In the future, Deep Blue Ocean Bio-Pharmaceutical will continue to deepen its efforts in the field of pharmaceutical research and development, implement the innovation-driven development strategy, strengthen construction in industrial technological innovation, transformation of scientific and technological achievements, and training of high-level technical talents. It will adhere to the concept of open communication, industry-university-research cooperation, and collaborative innovation, connect the industrial chain upstream and downstream, and help improve the overall technical level of the pharmaceutical industry in Henan Province.
-END-
轉(zhuǎn)載聲明：未經(jīng)本網(wǎng)或本網(wǎng)權(quán)利人授權(quán)，不得轉(zhuǎn)載、摘編或利用其他方式使用上述作品。已經(jīng)本網(wǎng)或本網(wǎng)權(quán)利人授權(quán)使用作品的，應(yīng)在授權(quán)范圍內(nèi)使用，并注明“來(lái)源：新領(lǐng)先醫(yī)藥科技”。
010-83057670
Address：
Marketing Department：
Leadingpharm
Pharm News
010-61006450
